BlackRock Inc. - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 2 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2022$7,916,000
-27.7%
34,392,362
+12.3%
0.00%
Q4 2021$10,956,000
-33.3%
30,631,558
+12.1%
0.00%
Q3 2021$16,422,000
-44.2%
27,321,653
+3.1%
0.00%
-100.0%
Q2 2021$29,416,000
+202.3%
26,501,101
+248.6%
0.00%
Q1 2021$9,731,000
+880.0%
7,602,535
+416.6%
0.00%
Q4 2020$993,000
-19.7%
1,471,6540.0%0.00%
Q3 2020$1,236,0001,471,654
+2776605.7%
0.00%
Q2 2020$0530.0%0.00%
Q1 2020$053
+1.9%
0.00%
Q4 2019$0520.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q2 2022
NameSharesValueWeighting ↓
Virtu Financial LLC 734,477$441,0000.04%
GSA CAPITAL PARTNERS LLP 516,218$310,0000.03%
Game Plan Financial Advisors, LLC 27,216$16,0000.01%
MONECO Advisors, LLC 35,000$21,0000.01%
Purus Wealth Management, LLC 15,000$9,0000.01%
Renaissance Technologies 6,038,664$3,630,0000.01%
Qube Research & Technologies Ltd 540,878$325,0000.00%
D. E. Shaw & Co., Inc. 6,690,867$4,022,0000.00%
Cutter & CO Brokerage, Inc. 19,000$11,0000.00%
Van Hulzen Asset Management, LLC 18,200$11,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders